2012 Aarkstore.com | HIV, AIDS, Pipeline, Review, H2, 2012

Document Sample
2012 Aarkstore.com | HIV, AIDS, Pipeline, Review, H2, 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

HIV / AIDS – Pipeline Review, H2 2012


You can also request for sample page of above mention reports on
sample@aarkstore.com



Summary

Global Markets Direct’s, HIV / AIDS - Pipeline Review, H2 2012, provides an
overview of the HIV / AIDS therapeutic pipeline. This report provides information
on the therapeutic development for HIV / AIDS, complete with latest updates, and
special features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for HIV / AIDS. HIV / AIDS - Pipeline
Review, H2 2012 is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for HIV / AIDS.
- A review of the HIV / AIDS products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Table of contents:

List of Tables 8
List of Figures 13
Introduction 14
Global Markets Direct Report Coverage 14
HIV / AIDS Overview 15
Therapeutics Development 16
An Overview of Pipeline Products for HIV / AIDS 16
HIV / AIDS Therapeutics under Development by Companies 18
HIV / AIDS Therapeutics under Investigation by Universities/Institutes 28
Late Stage Products 34
Comparative Analysis 34
Mid Clinical Stage Products 35
Comparative Analysis 35
Early Clinical Stage Products 36
Comparative Analysis 36
Discovery and Pre-Clinical Stage Products 37
Comparative Analysis 37
HIV / AIDS Therapeutics – Products under Development by Companies 38
HIV / AIDS Therapeutics – Products under Investigation by Universities/Institutes
51
Companies Involved in HIV / AIDS Therapeutics Development 68
Bristol-Myers Squibb Company 68
Johnson & Johnson 69
Abbott Laboratories 70
Vical Incorporated 71
Shionogi & Co., Ltd. 72
GlaxoSmithKline plc 73
Nektar Therapeutics 74
Inovio Biomedical Corporation 75
Gilead Sciences, Inc. 76
VIRxSYS Corporation 77
Merck & Co., Inc. 78
United Biomedical, Inc. 79
Lentigen Corporation 80
Myriad Genetics, Inc. 81
Sangamo BioSciences, Inc. 82
Cytokine PharmaSciences, Inc. 83
Generex Biotechnology Corporation 84
Ceragenix Pharmaceuticals, Inc. 85
Nanotherapeutics, Inc. 86
Ambrilia Biopharma Inc. 87
Panacos Pharmaceuticals, Inc. 88
Biotron Limited 89
Aphios Corporation 90




List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1




Astrocytoma – Pipeline Review, H2 2012

Autoimmune Disorders – Pipeline Review, H2 2012

HIV / AIDS – Pipeline Review, H2 2012

Contraceptives – Pipeline Review, H2 2012
Metastatic Prostate Cancer – Pipeline Review, H2 2012

Fungal Infections – Pipeline Review, H2 2012

Mycobacterium Infections – Pipeline Review, H2 2012

Brain Cancer – Pipeline Review, H2 2012

Metastatic Colorectal Cancer – Pipeline Review, H2 2012

Orthomyxoviridae Infections – Pipeline Review, H2 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:11
posted:9/13/2012
language:English
pages:4